Next |
home / stock / veru / veru message board
Subject | By | Source | When |
---|---|---|---|
$VERU...............................https://stockcharts.com/h-sc/ui?s=$VERU&p=W&b= | glenn1919 | investorshub | 04/22/2023 12:20:37 PM |
Ther meme stock..good nws | Jayzp | investorshub | 04/21/2023 2:33:21 PM |
I still say in my opinion the shareholders | Alleyba1 | investorshub | 02/23/2023 3:41:42 PM |
I believe in the latest $VERU filing Blackrock | Alleyba1 | investorshub | 02/13/2023 5:42:12 PM |
$VERU.................................https://stockcharts.com/h-sc/ui?s=$VERU&p=W& | glenn1919 | investorshub | 02/10/2023 9:22:33 PM |
I still say in my opinion the shareholders | Alleyba1 | investorshub | 02/09/2023 5:35:26 PM |
Never mess with the FDA. They only approve | Harbor6460 | investorshub | 02/03/2023 5:54:45 PM |
No, just investors fed up with the games. | GlitchMatrix | investorshub | 01/27/2023 4:17:15 PM |
Yea, that didn't help. And it looks shady | Gman3343 | investorshub | 01/25/2023 1:45:16 AM |
I still say in my opinion the shareholders | Alleyba1 | investorshub | 01/24/2023 8:11:43 PM |
Very sad, they could be helping people. But | Gman3343 | investorshub | 01/19/2023 1:43:29 AM |
G-Man, I totally agree with you. The FDA was | Alleyba1 | investorshub | 01/18/2023 9:05:27 PM |
Is this just another frivolous lawsuit by a | cfoofme | investorshub | 12/14/2022 7:27:27 PM |
It's ridiculous, that drug should have gotten approved. | Gman3343 | investorshub | 12/13/2022 1:10:18 PM |
I totally agree with your comments. If this | Alleyba1 | investorshub | 12/12/2022 5:46:37 PM |
So, what are we saying ~ all is | klarino man | investorshub | 11/17/2022 8:29:19 PM |
I totally agree with you. Statistically the numbers | Alleyba1 | investorshub | 11/16/2022 8:46:45 PM |
No, why would that happen ? Drug was | Gman3343 | investorshub | 11/14/2022 1:33:45 PM |
A good chance that $VERU will force some | blueazur | investorshub | 11/14/2022 1:17:55 PM |
Yes, that is very suspicious. | Gman3343 | investorshub | 11/12/2022 12:32:33 AM |
News, Short Squeeze, Breakout and More Instantly...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. Net revenue (managed) ...